The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
NEW ISSUE
Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …
February 19, 2021
NEW
Ahead of Print: OCT findings in ESR
Jincheng Guo et al.
February 24, 2021
Editorial
Consolidating the value of the standardised ARC-HBR definition
Giuseppe Gargiulo et al.
February 24, 2021
SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH
(Thanks to the support of Biotronik)
February 28, 2021
Guidance Papers
Guidelines, consensus & position papers
August 28, 2020
JAA
This weeks JAA's: IVUS Guidewire Locations During Retrograde CTO, TF-TAVI endovascular closing and more..
February 16, 2021
NEW
The Year in Review
M. Lunardi et al.
January 22, 2021

The editor's choice

CORONARY
Prognostic significance of thermodilution-derived coronary flow capacity in patients with deferred revascularisation
Masahiro Hoshino
Hoshino M et al
February 19, 2021
10.4244/EIJ-D-19-00029
CORONARY
Ticagrelor versus clopidogrel in patients with STEMI treated with thrombolysis: the MIRTOS trial
Michalis Hamilos
Hamilos M et al
February 19, 2021
10.4244/EIJ-D-20-00268
CORONARY
High bleeding risk and clinical outcomes in East Asian patients undergoing percutaneous coronary intervention: the PENDULUM registry
Masato Nakamura
Nakamura M et al
February 19, 2021
10.4244/EIJ-D-20-00345
Valvular disease
Heterogeneity of debris captured by cerebral embolic protection filters during TAVI
Herbert Kroon
Kroon H et al
February 19, 2021
10.4244/EIJ-D-20-00744

Latest articles

Infective endocarditis after TAVI; IVUS assessment in valve-in-valve procedures; a mini focus on antithrombotic therapy in coronary interventions; an EAPCI position statement on elective procedures during COVID-19; and more…
Capodanno D
February 19, 2021
Cerebral embolic protection during TAVI: the game is not over
Bagur R, Sposato L
February 19, 2021 | 10.4244/EIJV16I14A201
Consolidating the value of the standardised ARC-HBR definition
Gargiulo G, Esposito G
February 19, 2021 | 10.4244/EIJV16I14A202
Thrombolysis in ST-elevation myocardial infarction is not dead
Kala P
February 19, 2021 | 10.4244/EIJV16I14A203
Ischaemic risk stratification after deferral of revascularisation on the basis of fractional flow reserve
Echavarría-Pinto M, van de Hoef T
February 19, 2021 | 10.4244/EIJV16I14A204
A review of recommendations for infective endocarditis prevention in patients undergoing transcatheter aortic valve implantation
Conen A, Stortecky S, Moreillon P, Hannan M, Franzeck F, Jeger R, Widmer A
February 19, 2021 | 10.4244/EIJ-D-19-00993
Heterogeneity of debris captured by cerebral embolic protection filters during TAVI
Kroon H, von der Thusen J, Ziviello F, van Wiechen M, Ooms J, Kardys I, Schipper M, van Gils L, Daemen J, de Jaegere P, Van Mieghem N
February 19, 2021 | 10.4244/EIJ-D-20-00744
Intravascular ultrasound assessment of coronary ostia following valve-in-valve transcatheter aortic valve implantation
Pighi M, Lunardi M, Pesarini G, Castriota F, Venturi G, Gottin L, Scarsini R, Ferrero V, Ribichini F
February 19, 2021 | 10.4244/EIJ-D-20-00611
Intravascular ultrasound guidance for valve-in-valve transcatheter pulmonary valve replacement
Kalinczuk L, Swierczewski M, Mintz G, Demkow M
February 19, 2021 | 10.4244/EIJ-D-20-00427
High bleeding risk and clinical outcomes in East Asian patients undergoing percutaneous coronary intervention: the PENDULUM registry
Nakamura M, Kadota K, Nakao K, Nakagawa Y, Shite J, Yokoi H, Kozuma K, Tanabe K, Iijima R, Harada A, Kuroda T, Murakami Y
February 19, 2021 | 10.4244/EIJ-D-20-00345
Ticagrelor versus clopidogrel in patients with STEMI treated with thrombolysis: the MIRTOS trial
Hamilos M, Kanakakis J, Anastasiou I, Karvounis C, Vasilikos V, Goudevenos J, Michalis L, Koutouzis M, Tsiafoutis I, Raisakis K, Stakos D, Hahalis G, Vardas P
February 19, 2021 | 10.4244/EIJ-D-20-00268
A prospective, multicentre, randomised, open-label trial to compare the efficacy and safety of clopidogrel versus ticagrelor in stabilised patients with acute myocardial infarction after percutaneous coronary intervention: rationale and design of the TALOS-AMI trial
Park M, Kim C, Kim M, Choo E, Hwang B, Park C, Kim H, Yoo K, Jeon D, Jeong M, Seung K, Ahn Y, Chang K
February 19, 2021 | 10.4244/EIJ-D-20-00187
Performing elective cardiac invasive procedures during the COVID-19 outbreak: a position statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI)
Chieffo A, Tarantini G, Naber C, Barbato E, Roffi M, Stefanini G, Buchanan G, Buszman P, Moreno R, Zawiślak B, Cayla G, Danenberg H, Da Silveira J, Nef H, James S, Mauri Ferre J, Voskuil M, Witt N, Windecker S, Baumbach A, Dudek D
February 19, 2021 | 10.4244/EIJ-D-20-01291
Neointimal hyperplasia of ultra-thin stents with microcrystalline sirolimus or durable polymer everolimus-eluting stents: 6- and 24-month results of the DESSOLVE III OCT study
Milewski K, Takahashi K, Asano T, Katagiri Y, Hochul M, Buszman P, Tomaniak M, Gorycki B, Zurakowski A, Janas A, Mlodziankowski A, Kachel M, Wykrzykowska J, Wijns W, de Winter R, Buszman P, Onuma Y, Serruys P
February 19, 2021 | 10.4244/EIJ-D-18-01201
Prognostic significance of thermodilution-derived coronary flow capacity in patients with deferred revascularisation
Hoshino M, Kanaji Y, Hamaya R, Kanno Y, Hada M, Yamaguchi M, Sumino Y, Usui E, Murai T, Lee T, Yonetsu T, Kakuta T
February 19, 2021 | 10.4244/EIJ-D-19-00029
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke